GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis

Published:2020-04-04 Issue:7 Volume:267 Page:2117-2122
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Malhotra Konark,Katsanos Aristeidis H.,Lambadiari Vaia,Goyal Nitin,Palaiodimou Lina,Kosmidou Maria,Krogias Christos,Alexandrov Andrei V.,Tsivgoulis Georgios

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/s00415-020-09813-4.pdf

Reference18 articles.

1. Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Ryden L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T (2019) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet (London, England) 394(10193):121–130. https://doi.org/10.1016/s0140-6736(19)31149-3

2. Baker L, Juneja R, Bruno A (2011) Management of hyperglycemia in acute ischemic stroke. Curr Treat Options Neurol 13(6):616–628. https://doi.org/10.1007/s11940-011-0143-8

3. Tsivgoulis G, Katsanos AH, Mavridis D, Lambadiari V, Roffe C, Macleod MJ, Sevcik P, Cappellari M, Nevsimalova M, Toni D, Ahmed N (2019) Association of baseline hyperglycemia with outcomes of patients with and without diabetes with acute ischemic stroke treated with intravenous thrombolysis: a propensity score-matched analysis from the SITS-ISTR registry. Diabetes 68(9):1861–1869. https://doi.org/10.2337/db19-0440

4. Lu GD, Ren ZQ, Zhang JX, Zu QQ, Shi HB (2018) Effects of diabetes mellitus and admission glucose in patients receiving mechanical thrombectomy: a systematic review and meta-analysis. Neurocrit Care 29(3):426–434. https://doi.org/10.1007/s12028-018-0562-4

5. Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus (2012) In: Committee for Medicinal Products for Human Use, London, European Medicines Society

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The G Protein-First Mechanism for Activation of the Class B Glucagon-like Peptide 1 Receptor Coupled to N-Terminal Domain-Mediated Conformational Progression;Journal of the American Chemical Society;2024-09-12

2. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases;European Heart Journal;2024-08-30

3. Definite benefits of GLP-1 receptor agonists: what is the risk of gastroparesis and lung aspiration?;Gut;2024-08-17

4. The evolving role of GLP-1 agonists in ischemic stroke prevention in diabetic patients;Cardiovascular Endocrinology & Metabolism;2024-08-14

5. Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs;Journal of Clinical Medicine;2024-08-09